Brooks Automation, BioCision announce equity investment, strategic collaboration

Brooks Automation and BioCision announced they have established a relationship to support the development of technologies to improve temperature control and standardization in the use of biomaterials across multiple industries, including pre-clinical and clinical research and product development. Under the terms of the agreement, Brooks Automation has made a $4M equity investment in BioCision. This new collaboration will leverage BioCision's proven expertise in the development of unique mobile temperature management products and technologies together with Brooks Automation's advanced research and production capabilities in automated systems for sample storage. The research and product design and engineering teams from both companies will work together to advance development of new, highly adaptable and scalable products to support a range of needs in biomaterial sample handling and biobanking, including products that are fully compatible with existing automated systems and that can serve as stand-alone solutions.